Corcept Therapeutics Incorporated
Redwood City, CA
- UEI
- MMA8PS1NF6M8
- CAGE
- 6MB68
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 101 Redwood Shores Pkwy, Redwood City, CA 94065, USA
- Website
- corcept.com
- Founded
- 1998
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
| GC Biopharma Usa, Inc. | Teaneck, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Soleno Therapeutics Inc. | Redwood City, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Cipla USA Inc. | Warren, NJ | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Corcept Therapeutics Incorporated, doing business as Corcept, is a for-profit organization registered to receive awards from the U.S. federal government since December 21, 2011. The company specializes in providing pharmaceutical products and services to federal agencies, particularly in the areas of drugs, pharmaceuticals, and hematology-related products. While specific details about the company's background are not provided, it is evident from the federal award history that Corcept focuses on supplying specialized medications, such as Korlym, to government healthcare providers.
Corcept currently holds multiple federal contract Indefinite Delivery Vehicles (IDVs) with civilian agencies. The company has been awarded a Blanket Purchase Agreement (BPA) by the National Acquisition Center with a ceiling value of $1,453,245.00 for the procurement of Korlym products and services, set to expire on September 23, 2025. Additionally, Corcept holds a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs, specifically the Veterans Integrated Service Network 12 (VISN 12), for drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B category. This multiple-award contract has a ceiling value of $1,000,000.00 and runs until August 31, 2029. Another significant BPA held by Corcept, also awarded by the National Acquisition Center, is for the supply of Korlym under the GSA Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. This single-award agreement has a ceiling value of $3,700,000.00 and is set to conclude on September 5, 2024. These IDVs demonstrate Corcept's role as a key supplier of specialized pharmaceutical products to federal healthcare agencies.
Quick answers
Is Corcept Therapeutics Incorporated registered in SAM.gov?
Yes. Corcept Therapeutics Incorporated's SAM.gov registration is active through July 24, 2027.
Which contract vehicles does Corcept Therapeutics Incorporated hold?
Corcept Therapeutics Incorporated holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Corcept Therapeutics Incorporated's most recent federal award?
Corcept Therapeutics Incorporated's most recent federal contract award is Mifepristone (36C26118F1932), from Veterans Integrated Service Network 21 (VHA), on June 22, 2018.
On GovTribe
See Corcept Therapeutics Incorporated's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors